Geode Capital Management
PHIO icon

Geode Capital Management’s Phio Pharmaceuticals PHIO Stock Holding History

Geode Capital Management’s Portfolio PHIO Stock Details PHIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$180K Buy
147,254
+54,616
+59% +$62.3K ﹤0.01% 3948
2025
Q4 		$97.3K Buy
92,638
+34,732
+60% +$55.6K ﹤0.01% 4108
2025
Q3 		$144K Buy
57,906
+212
+0.4% +$483 ﹤0.01% 4033
2025
Q2 		$136K Buy
57,694
+16,108
+39% +$32.6K ﹤0.01% 3986
2025
Q1 		$54.1K Buy
+41,586
New +$76.8K ﹤0.01% 4186
2024
Q3 		– Sell
-3,126
Closed -$19.7K – 4570
2024
Q2 		$19.7K Buy
+3,126
New +$20.4K ﹤0.01% 4455
2023
Q4 		– Sell
-1,692
Closed -$22.8K – 4674
2023
Q3 		$22.8K Buy
+1,692
New +$35.1K ﹤0.01% 4592
2023
Q1 		– Sell
-990
Closed -$39K – 4822
2022
Q4 		$39K Sell
990
-3
-0.3% -$154 ﹤0.01% 4659
2022
Q3 		$61K Hold
993
– – ﹤0.01% 4720
2022
Q2 		$77K Hold
993
– – ﹤0.01% 4674
2022
Q1 		$95K Hold
993
– – ﹤0.01% 4677
2021
Q4 		$107K Hold
993
– – ﹤0.01% 4709
2021
Q3 		$216K Buy
993
+183
+23% +$38.2K ﹤0.01% 4417
2021
Q2 		$197K Hold
810
– – ﹤0.01% 4347
2021
Q1 		$234K Buy
810
+622
+331% +$207K ﹤0.01% 4066
2020
Q4 		$54K Buy
+188
New +$47.5K ﹤0.01% 4157
2018
Q1 		– Hold
0
– -$14K – 4068
2017
Q4 		– Hold
0
– – – 4004
2017
Q3 		– Hold
0
– – – 4033
2017
Q2 		– Hold
0
– – – 4061
2017
Q1 		– Hold
0
– – – 4038
2016
Q4 		– Hold
0
– – – 4006
2016
Q3 		– Hold
0
– – – 3922
2016
Q2 		– Hold
0
– – – 3891
2016
Q1 		– Hold
0
– – – 3908
2015
Q4 		– Hold
0
– – – 3879
2015
Q3 		– Hold
0
– – – 3896
2015
Q2 		– Hold
0
– – – 3713
2015
Q1 		– Hold
0
– – – 3839
2014
Q4 		– Hold
0
– – – 3719
2014
Q3 		– Hold
0
– – – 3631
2014
Q2 		– Hold
0
– – – 3734
2014
Q1 		– Hold
0
– – – 3647

Other funds holding PHIO

Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
SRL
Scientech Research LLC Jersey City, New Jersey $120M AUM 73.62% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management's PHIO Position: Q1 2026 in Review

Geode Capital Management increased its Phio Pharmaceuticals (PHIO) stake by 59% in Q1 2026, buying an estimated $62.3K and bringing the position to 147,254 shares worth $180K. The position accounts for ﹤0.01% of the portfolio, ranked #3948.

Geode Capital Management first reported a position in PHIO in Q4 2020 and has held it in 16 quarters since. The position peaked at $234K in Q1 2021. 24 funds tracked by Wall St. Rank hold PHIO as of Q1 2026.

  • Geode Capital Management held 147,254 shares of Phio Pharmaceuticals worth $180K as of Q1 2026.
  • Geode Capital Management bought 54,616 Phio Pharmaceuticals shares in Q1 2026, an estimated $62.3K.
  • Phio Pharmaceuticals made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #3948 holding.
  • Geode Capital Management first reported a position in Phio Pharmaceuticals in Q4 2020 and has held it in 16 quarters since.
  • Geode Capital Management's Phio Pharmaceuticals position peaked at $234K in Q1 2021.
  • 24 funds tracked by Wall St. Rank held Phio Pharmaceuticals as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.